Home › Products › Infectious Disease › Berirab P 300IU Injection
Berirab P 300IU Injection
Salt Composition: HUMAN RABIES IMMUNOGLOBULIN
- Manufacturer: BHARAT SERUMS & VACCINES LTD
- Pack Size: 1 PREFILLED SYRINGE(s) OF 2ML
- Dosage Form: INJECTION
- Strength: 300IU
- Prescription Required
- Cold Chain
- Prepaid Only. Non-Returnable.
- Storage: Store in a refrigerator between 2°C to 8°C (36°F to 46°F). Keep away from moisture, heat, and light. It should not be frozen. Keep it in its original packaging until it is ready to be used. Keep out of the reach of children and pets.
₹4672.00₹5840.19
Inclusive of all taxes
Product Introduction
Berirab P 300IU Injection contains the active agent Human Rabies Immunoglobulin (HRIG). It is indicated to prevent passive, transient rabies infection after exposure to a rabid animal including dogs, mongoose, jackals, and foxes. This injection is formulated from blood plasma from screened donors. Rabies infection spreads when a person is bitten, scratched, or licked by an infected animal, especially when the skin is already injured. Rabies is a serious and often fatal viral disease that can cause severe neurological symptoms, including fever, headache, muscle weakness, and paralysis. Once symptoms develop, the disease is almost always fatal. Though this infection is 100% fatal, it is 100% preventable with timely measures and the correct use of available vaccines, immunoglobulins, or monoclonal antibodies. Patients with a history of severe allergic reactions to Berirab P 300IU Injection or any of its components should not receive this medication. This injection is prepared from human plasma and may contain infectious agents that can cause disease. Report to your physician immediately if you experience symptoms like headache, nausea, fever, vomiting, weakness, muscle pain, or diarrhoea, as these symptoms indicate a possible viral infection. Paediatric patients require special considerations regarding the use of Berirab P 300IU Injection. It can be used in elderly individuals, but the dose and administration may need adjustment based on age, weight, and health status.
Uses
Prevention of rabies infection post-exposure to a rabid animal
How it works
The therapeutic effect of Berirab P 300IU Injection is to prevent or treat rabies infection. It works by providing immediate, passive immunity to the rabies virus by neutralizing the virus before it can infect the body's cells and cause disease. It is usually given along with the rabies vaccine, which helps the body develop its own antibodies against the virus.
How to Use
Berirab P 300IU Injection is administered as an injection, usually by a healthcare professional. The injection is typically given into the muscle or at the site of the bite wound.
Side Effects
Berirab P 300IU Injections cause some side effects like all medications, although not everyone will experience them. Serious: Severe allergic reactions Respiratory distress Blood pressure changes Seizures or convulsions Chest pain Unusual warmth of limb Common: Pain, swelling, or redness at the injection site Fever Headache Nausea Dizziness
Expert Tips
It is important to carefully read and understand the warnings and precautions associated with the medication. Patients should report to the doctor if they have any infusion reactions. Pregnant and breastfeeding women should consult with a healthcare provider before taking it. Be sure to inform your healthcare provider of any allergies, medical conditions, or medications you take. Berirab P 300IU Injection may also interfere with the immune response to live virus vaccines, and there is a small risk of transmitting blood-borne infections. Always maintain a healthy and balanced diet to support your overall health and well-being.
References
- Bio Products Laboratory Limited, Electronic Medicines Compendium (EMC), [Revised on Sep 2020] [Accessed on 10th May 2023], https://www.medicines.org.uk/emc/files/pil.5543.pdf
- Kedrion Biopharma Inc., US Food & Drug Administration, [Revised on 2020] [Accessed on 10th May 2023], https://www.fda.gov/media/106795/download
- Sudarshan MK. World Health Organization 2018 Guidelines on Rabies Prophylaxis: Contentious Issues. Pediatr Inf Dis 2019;1(4):154â156, https://www.pidjournal.com/doi/PID/pdf/10.5005/jp-journals-10081-1226
Safety Advice
Pregnancy: Consult your doctor Pregnant women should consult their healthcare provider about their pregnancy status before receiving Berirab P 300IU Injection.
Lungs: Consult your doctor In individuals with lung conditions such as asthma or chronic obstructive pulmonary disease (COPD), Berirab P 300IU Injection can cause shortness of breath or worsen respiratory symptoms.
Breastfeeding: Consult your doctor It is unknown if Berirab P 300IU Injection is excreted in human breast milk, so breastfeeding women should consult a healthcare provider before taking the injection.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.